This site is intended only for healthcare professionals resident in Egypt

Search

Menu

Close

Sign InLog Out Our medicinesTherapy areasExplore contentExplore contentEventsDownloadable materialsVideosLet’s connectLet's ConnectContact usAsk a questionPfizer medical information

Menu

Close

Clinical Information​Stroke Prevention in Atrial Fibrillation​Morbidity and Mortality​Efficacy​Aristophanes​Safety​Real-world Data​Guideline recommendations​Persistence and Adherence​Dosing​Summary​Venous Thromboembolism TreatmentEfficacySafety​Real-world Data​Guideline recommendationsDosing​Venous Thromboembolism PreventionEfficacy​Safety​Dosing​Eliquis Important Safety InformationEliquis Abbreviated Prescribing Information (2.5 mg)​Eliquis Abbreviated Prescribing Information (5 mg) Support & Services​ Support & Services​ Self-detail presentations​ Webinars​ Videos​
Videos​

Egypt Increased Risk of thrombotic events in AF patients with different comorbidities Video EGY

Click hereLoading

PP-ELI-EGY-0464

Video Anticoagulation in Elderly 2023 Egypt

Click hereLoading

PP-ELI-EGY-0458

Egypt Eliquis Comorbidities with Atrial Fibrillation Video 2023

Click hereLoading

PP-ELI-EGY-0456

Explore more
VTE treatment Guideline recommendations​
 Learn more LoadingQuick Links
VTE treatment Dosing​
 Learn more Loading
SPAF Real-world Data​
 Learn more Loading
Click here for Eliquis® 2.5mg Prescribing Information

Click here for Eliquis® 5mg Prescribing Information

 
 
HF0098OA451/122022
Invalidation Date : 21/08/2024
HF0098OA452/122022
Invalidation Date : 21/08/2024
HF0098OA455/122022
Invalidation Date : 21/08/2024
 HF0098OA456/122022
Invalidation Date : 21/08/2024
PP-ELI-EGY-0467

Adverse events should be reported. Adverse events can be reported to [email protected]

PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign inRegisterAccountSign Out

The product information provided in this site is intended only for Healthcare Professionals of Egypt. The products discussed herein may have different product labeling in different countries. 

 

Copyright © 2023 Pfizer biopharmaceutical LLC. All rights reserved.

 

PP-UNP-EGY-0064
You are leaving the Pfizer for Professionals website
​
You are being directed to a third-party website:

This link is provided for your convenience. Please note that this third-party website is not controlled by Pfizer for Professionals or subject to our privacy policy.
 
PP-UNP-EGY-0064
For Healthcare Professionals only

These pages are not intended for patients or members of the general public. This portal contains healthcare promotional content.
 

If you select ‘No’, you will be redirected to Pfizer.com, the global Pfizer website.
 

I confirm that I am a healthcare professional resident in Egypt.
 

PP-UNP-EGY-0064

Yes No